Hwang, B G (2006) Development of a performance measurement system for the delivery of pharmaceutical capital facility projects. PhD thesis, University of Texas at Austin, USA.
Abstract
This research documents the development of a performance measurement system for the delivery of pharmaceutical capital facility projects. The purpose of this research is to develop a system for evaluating pharmaceutical projects with metrics specific to the characteristics of these unique projects. The pharmaceutical industry is unique in its procedures and methods of manufacture and thus requires a distinct project management approach. The hypothesis for this research is that project performance tailored to the process of pharmaceutical projects can be measured, and that the industry norms may be established. There are six specific objectives that support main goal of this study: (1) Develop metrics tailored to pharmaceutical capital facility projects; (2) Develop a data collection system for validation and use of these metrics; (3) Collect data and develop a methodology for analysis; (4) Develop a reporting system that meets the needs of the industry for use of the metrics; (5) Validate and refine the performance measurement system based upon the collected data and industry experts’ opinions; and, finally (6) Provide lessons learned and recommend a direction for future studies. The primary contribution of this research is to provide the pharmaceutical industry a standard system for quantifying performance of their capital facility projects, ultimately establishing a methodology of developing the system for other industries. To do so, this research will provide a hierarchical structure of pharmaceutical project types as a framework enabling pharmaceutical projects to be properly grouped and benchmarked. Moreover, this research will produce industry-specific metrics tuned to the processes of pharmaceutical projects. Effective utilization of the metrics produced through this research requires their adjustment for location and time to ensure meaningful comparisons. Thus, procedures will be developed to produce a project database maintained in current dollars at a common location. In addition, this research will provide project performance norms for the principal pharmaceutical project types and will produce a customized report effectively showing and comparing project performance with the existing CII BM&M database as well as the pharmaceutical project database developed by this research.
| Item Type: | Thesis (Doctoral) |
|---|---|
| Thesis advisor: | Thomas, S R and Caldas, C H |
| Uncontrolled Keywords: | measurement; industry norms; project performance; validation |
| Index terms: | project performance, future study, project management, performance measurement, database, documents, validation, industry norm, methodology, norms, lessons learned |
| Subjects: | business, research design and methodology, performance measurement, research methods, professional development, project management theory and practice, data management, sociology |
| Topics: | Digital Applications, Business Strategy, Information Management, Research Practice, Quality Management, Project Management |
| Descriptive scope: | 4 PCTA |
N.B. Descriptive scope is a count of how many of the five facets of empirical research are indicated by the words used in title, abstract and keywords. It is not intended as a judgement on the research; merely a count of the kind of word we would expect to indicate Phenomenon, Concepts, Theoretical framing, Empirical techniques, Analytical techniques. If all five are present, then a code of “5 PCTEA” will indicate this. If you feel the coding for this record is questionable, we welcome discussion around the terms we matched or the way we categorized them. The facet you would expect may not be coded, or a facet may be coded inappropriately. This can also bear on a larger question, of which facets should be treated as defining in construction management research. Please get in touch, and we will look at it. More details here